177 related articles for article (PubMed ID: 23559427)
1. Association of the dopamine β-hydroxylase 19 bp insertion/deletion polymorphism with positive symptoms but not tardive dyskinesia in schizophrenia.
Zhou N; Yu Q; Li X; Yu Y; Kou C; Li W; Xu H; Luo X; Zuo L; Kosten TR; Zhang XY
Hum Psychopharmacol; 2013 May; 28(3):230-7. PubMed ID: 23559427
[TBL] [Abstract][Full Text] [Related]
2. Possible association between DBH 19 bp insertion/deletion polymorphism and clinical symptoms in schizophrenia with tardive dyskinesia.
Hui L; Han M; Huang XF; Ye MJ; Zheng K; He JC; Lv MH; Zhang BH; Soares JC; Zhang XY
J Neural Transm (Vienna); 2015 Jun; 122(6):907-14. PubMed ID: 25336319
[TBL] [Abstract][Full Text] [Related]
3. Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia.
Hui L; Han M; Yin GZ; Zhang Y; Huang XF; Qian ZK; Gu WG; Gu XC; Zhu XM; Soares JC; Ning Y; Zheng Y; Du XD; Zhang XY
Schizophr Res; 2017 Apr; 182():104-109. PubMed ID: 27776953
[TBL] [Abstract][Full Text] [Related]
4. The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia.
Hui L; Zhang X; Huang XF; Han M; Fernandez F; Yu Y; Sun S; Li W; Chen DC; Xiu MH; Kosten TR; Zhang XY
J Psychiatr Res; 2012 Jun; 46(6):733-7. PubMed ID: 22445279
[TBL] [Abstract][Full Text] [Related]
5. Association between DBH 19 bp insertion/deletion polymorphism and cognition in first-episode schizophrenic patients.
Hui L; Zhang X; Yu YQ; Han M; Huang XF; Chen DC; Wang ZR; Du WL; Kou CG; Yu Q; Kosten TR; Zhang XY
Schizophr Res; 2013 Jul; 147(2-3):236-40. PubMed ID: 23707643
[TBL] [Abstract][Full Text] [Related]
6. Association of regulatory variants of dopamine β-hydroxylase with cognition and tardive dyskinesia in schizophrenia subjects.
Punchaichira TJ; Mukhopadhyay A; Kukshal P; Bhatia T; Deshpande SN; Thelma BK
J Psychopharmacol; 2020 Mar; 34(3):358-369. PubMed ID: 31913053
[TBL] [Abstract][Full Text] [Related]
7. Association between DβH 5'-insertion/deletion polymorphism and cognition in patients with chronic schizophrenia.
Hui L; Han M; Huang XF; Ye MJ; Zhang X; He JC; Lv MH; Soares JC; Zhang XY
J Clin Psychiatry; 2016 Mar; 77(3):379-85. PubMed ID: 26891013
[TBL] [Abstract][Full Text] [Related]
8. The interaction of polymorphisms of IL10 and DBH was associated with general symptoms of PANSS with TD in Chinese Han schizophrenic patients.
Sun H; Wang F; Fan H; Yan Q; Cui K; Yuan W; Zhao F; Zhao L; Yuan J; Yang F; Kosten TR; Zhang XY
PLoS One; 2013; 8(8):e70963. PubMed ID: 23951054
[TBL] [Abstract][Full Text] [Related]
9. Association of functional dopamine-beta-hydroxylase (DBH) 19 bp insertion/deletion polymorphism with smoking severity in male schizophrenic smokers.
Zhang XY; Chen DC; Xiu MH; Hui L; Liu H; Luo X; Zuo L; Zhang H; Kosten TA; Kosten TR
Schizophr Res; 2012 Oct; 141(1):48-53. PubMed ID: 22871345
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
[TBL] [Abstract][Full Text] [Related]
11. Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.
Hitzeroth A; Niehaus DJ; Koen L; Botes WC; Deleuze JF; Warnich L
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):664-72. PubMed ID: 17291655
[TBL] [Abstract][Full Text] [Related]
12. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
[TBL] [Abstract][Full Text] [Related]
13. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
Himei A; Koh J; Sakai J; Inada Y; Akabame K; Yoneda H
Psychiatry Clin Neurosci; 2002 Feb; 56(1):97-102. PubMed ID: 11929577
[TBL] [Abstract][Full Text] [Related]
14. [Lack of association between 141C Ins/Del promoter polymorphism of DRD2 gene and schizophrenia].
Kapelski P; Czerski PM; Godlewski S; Dmitrzak-Weglarz M; Hauser J
Psychiatr Pol; 2002; 36(3):413-9. PubMed ID: 12149917
[TBL] [Abstract][Full Text] [Related]
15. Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients.
Liu H; Wang C; Chen PH; Zhang BS; Zheng YL; Zhang CX; Meng HQ; Wang Y; Chen DC; Xiu MH; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):692-6. PubMed ID: 20346996
[TBL] [Abstract][Full Text] [Related]
16. Association between dopamine beta-hydroxylase 19-bp insertion/deletion polymorphism and major depressive disorder.
Zhou Y; Wang J; He Y; Zhou J; Xi Q; Song X; Ye Y; Ying B
J Mol Neurosci; 2015 Feb; 55(2):367-71. PubMed ID: 24888991
[TBL] [Abstract][Full Text] [Related]
17. [No association of 141C-ins/del polymorphism in the D2 dopamine receptor gene in schizophrenia].
Rohrmeier T; Putzhammer A; Sartor H; Knapp M; Albus M; Borrmann-Hassenbach M; Lichtermann D; Wildenauer D; Schwab S; Maier W; Klein HE; Eichhammer P
Psychiatr Prax; 2003 May; 30 Suppl 2():S212-5. PubMed ID: 14509080
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
[TBL] [Abstract][Full Text] [Related]
19. Reduced serum TNF alpha level in chronic schizophrenia patients with or without tardive dyskinesia.
Tian L; Tan Y; Chen D; Lv M; Tan S; Soares JC; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():259-64. PubMed ID: 24995685
[TBL] [Abstract][Full Text] [Related]
20. Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients.
Kang SG; Choi JE; An H; Park YM; Lee HJ; Han C; Kim YK; Kim SH; Cho SN; Joe SH; Jung IK; Kim L; Lee MS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1844-7. PubMed ID: 18790709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
